ARTICLE | Product Development
$1B AMR Action Fund to assess first investments in 1Q21
Plus: PASTEUR Act seeking $11B over 10 years to fund antibiotic subscription model
October 13, 2020 10:20 PM UTC
The $1 billion AMR Action Fund remains on track to begin assessing investment opportunities in 1Q21 aimed at addressing antimicrobial resistance.
In July, 23 pharmas banded together to create the fund to bridge the gap between Phase II testing and approval for biotechs trying to advance products that combat antimicrobial resistance against WHO or CDC-prioritized pathogens. ...